Overview
Mario Vallon practices in Wuerzburg, Germany. His top areas of expertise are Late-Onset Retinal Degeneration and Age-Related Macular Degeneration (ARMD).
His clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mario Vallon
Is Mario Vallon a top-rated expert for Late-Onset Retinal Degeneration?
MediFind is an objective health platform that identifies experts based on real-world data. Mario Vallon is classified as an Experienced expert for Late-Onset Retinal Degeneration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mario Vallon participate in research or clinical trials?
Yes. Mario Vallon has published 20 articles and abstracts on conditions like Late-Onset Retinal Degeneration. You can view a list of Mario Vallon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. Vallon isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Late-Onset Retinal DegenerationMr. Vallon isExperienced. Learn about Late-Onset Retinal Degeneration.